462 studies found for:    Open Studies | "Uterine Diseases"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Uterine Diseases"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Study of Laparoendoscopic Single Site Hysterectomy in Benign and Preinvasive Uterine Disease
Condition: Benign or Preinvasive Uterine Disease
Interventions: Procedure: Single-port LAVH;   Procedure: Three-port LAVH
2 Recruiting Feasibility and Benefit of Laparoscopic Hysterectomy With Less Than 3 Millimeter Diameter's Instruments in Current Practice
Condition: Benign Uterine Diseases
Intervention: Procedure: laparoscopic hysterectomy
3 Recruiting Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of SKI2670
Condition: Uterine Disease
Interventions: Drug: SKI2670;   Drug: Placebo
4 Recruiting Impact of Opportunistic Salpingectomy on Ovarian Reserve in Patients Undergoing Laparoscopic Hysterectomy
Condition: Benign Uterine Disease
Interventions: Procedure: LH alone;   Procedure: LH with opportunistic salpingectomy
5 Unknown  Study on Bladder and Sexual Function Change After Simple Hysterectomy
Condition: Benign Uterine Disease
6 Not yet recruiting Study of IMGN853 in Comb. With Bevacizumab, Carboplatin or PLD in Adults With FRa + Adv. EOC, Primary Peritoneal, Fallopian Tube, or Endometrial Cancer
Conditions: Epithelial Ovarian Cancer;   Primary Peritoneal Cancer;   Fallopian Tube Cancer;   Endometrial Cancer
Interventions: Drug: IMGN853;   Drug: Bevacizumab;   Drug: Carboplatin;   Drug: Doxorubicin
7 Not yet recruiting Minimize Menorrhagia in Women With Type 1 Von Willebrand Disease
Condition: Type 1 Von Willebrand Disease
Interventions: Drug: recombinant von Willebrand factor;   Drug: tranexamic acid
8 Recruiting DNA Methylation Biomarkers for Cervical Cancer Screening
Conditions: Cervical Intraepithelial Neoplasia;   Cervical Cancer
9 Not yet recruiting Evaluation of Sentinel Node Policy in Early Stage Endometrial Carcinomas at Intermediate and High Risk of Recurrence (SENTIRAD).
Condition: Endometrial Carcinoma
Interventions: Drug: Pre-operative Sentinel Node (SN) mapping with Nanocis;   Drug: Intra-operative Sentinel Node (SN) mapping with patent V blue dye;   Drug: Intra-operative Sentinel Node (SN) mapping with indocyanin green (Infracyanine);   Procedure: Full bilateral laparoscopic lymphadenectomy and Hysterectomy
10 Not yet recruiting Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vulvar Cancer
Conditions: Cervical Adenocarcinoma;   Cervical Adenosquamous Carcinoma;   Cervical Squamous Cell Carcinoma;   Stage IB Vulvar Cancer;   Stage IB2 Cervical Cancer;   Stage II Vulvar Cancer;   Stage IIA1 Cervical Cancer;   Stage IIA2 Cervical Cancer;   Stage IIB Cervical Cancer;   Stage IIIA Cervical Cancer;   Stage IIIA Vulvar Cancer;   Stage IIIB Cervical Cancer;   Stage IIIB Vulvar Cancer;   Stage IIIC Vulvar Cancer;   Stage IVA Cervical Cancer;   Stage IVA Vulvar Cancer;   Vulvar Adenocarcinoma;   Vulvar Squamous Cell Carcinoma
Interventions: Drug: Cisplatin;   Radiation: External Beam Radiation Therapy;   Radiation: High-Dose Rate Brachytherapy;   Radiation: Intensity-Modulated Radiation Therapy;   Radiation: Internal Radiation Therapy;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: Triapine
11 Recruiting Neoadjuvant Chemotherapy and Radical Surgery in Stage IIB Cervical Cancer
Condition: Cervical Carcinoma Stage IIB
Interventions: Radiation: Concurrent chemoirradiation;   Drug: Paclitaxel;   Procedure: Radical Surgery;   Drug: Cisplatin
12 Recruiting Adenomyosis and Ulipristal Acetate
Condition: Adenomyosis
Interventions: Drug: Ulipristal acetate;   Drug: Placebo
13 Not yet recruiting A Phase 1/2a Evaluation of the Safety and Efficacy of Adding AL3818 to Standard Platinum-Based Chemotherapy
Conditions: Endometrial Carcinoma;   Ovarian Carcinoma;   Fallopian Tube Carcinoma;   Primary Peritoneal Carcinoma;   Cervical Carcinoma
Interventions: Drug: AL3818;   Drug: Carboplatin;   Drug: Paclitaxel
14 Not yet recruiting Ultrasound Appearance of the Endometrium Post Radio-Frequency Ablation
Condition: Menorrhagia
Intervention: Other: Ultrasound
15 Recruiting Palliative Care in Improving Quality of Life in Patients With High Risk Primary or Recurrent Gynecologic Malignancies
Conditions: Cervical Carcinoma;   Ovarian Carcinoma;   Primary Peritoneal Carcinoma;   Recurrent Cervical Carcinoma;   Recurrent Ovarian Carcinoma;   Recurrent Uterine Corpus Carcinoma;   Recurrent Vulvar Carcinoma;   Uterine Corpus Cancer;   Vulvar Carcinoma;   Peritoneal Neoplasms
Interventions: Other: Palliative Therapy;   Other: Palliative Therapy + idiographic
16 Recruiting HPV Integration Testing for Human Papillomavirus-Positive Women
Conditions: Cervical Intraepithelial Neoplasia;   Cervical Cancer
Intervention: Procedure: TCT,HPV,colposcopic inspection
17 Recruiting HPV Integration Testing for Cervical Cancer Screening
Conditions: Cervical Cancer;   Cervical Intraepithelial Neoplasia
Intervention: Procedure: TCT,HPV,colposcopic inspection
18 Not yet recruiting Pilot Study In Vivo Confocal Microscopy Probe for Cervical Precancer
Conditions: Precancerous Condition;   Cervical Cancer
Intervention: Device: In Vivo Confocal Microscopy Probe
19 Not yet recruiting A Trial of Non-selective Versus Selective Adjuvant Therapy in High Risk Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Procedure: Lymphadenectomy;   Drug: Chemotherapy - regimen to be selected according to local site policy;   Radiation: Radiotherapy;   Radiation: Optional vaginal brachytherapy
20 Not yet recruiting Indocyanine Green Versus Blue Dye for Detection of Sentinel Lymph Node In Endometrial Cancer
Condition: Endometrial Neoplasms
Intervention: Procedure: Sentinel lymph node biopsy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years